See more : Health Revenue Assurance Holdings, Inc. (HRAA) Income Statement Analysis – Financial Results
Complete financial analysis of Pediatrix Medical Group, Inc. (MD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pediatrix Medical Group, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- BIMobject AB (BIM.ST) Income Statement Analysis – Financial Results
- RingCentral, Inc. (0V50.L) Income Statement Analysis – Financial Results
- Metropolitan Bank Holding Corp. (MCB) Income Statement Analysis – Financial Results
- Arko Corp. (ARKO.TA) Income Statement Analysis – Financial Results
- Daisho Microline Holdings Limited (0567.HK) Income Statement Analysis – Financial Results
Pediatrix Medical Group, Inc. (MD)
About Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.99B | 1.97B | 1.91B | 1.73B | 3.51B | 3.65B | 3.46B | 3.18B | 2.78B | 2.44B | 2.15B | 1.82B | 1.59B | 1.40B | 1.29B | 1.07B | 917.64M | 818.55M | 693.70M | 619.63M | 551.20M | 465.48M | 354.60M | 243.08M | 227.00M | 185.40M | 128.90M | 80.80M | 43.90M | 32.80M |
| Cost of Revenue | 1.57B | 1.50B | 1.40B | 1.28B | 2.62B | 2.66B | 2.46B | 2.15B | 1.85B | 1.63B | 1.44B | 1.20B | 1.04B | 912.43M | 835.73M | 688.21M | 567.38M | 501.55M | 27.68M | 24.25M | 18.59M | 15.79M | 0.00 | 26.68M | 21.10M | 14.10M | 9.80M | 6.30M | 3.50M | 2.80M |
| Gross Profit | 421.57M | 467.03M | 513.24M | 449.32M | 892.00M | 989.51M | 1.00B | 1.03B | 928.01M | 806.52M | 710.31M | 613.88M | 551.04M | 489.13M | 452.54M | 380.07M | 350.26M | 317.00M | 666.02M | 595.38M | 532.61M | 449.69M | 354.60M | 216.40M | 205.90M | 171.30M | 119.10M | 74.50M | 40.40M | 30.00M |
| Gross Profit Ratio | 21.13% | 23.68% | 26.85% | 25.91% | 25.39% | 27.13% | 28.92% | 32.47% | 33.38% | 33.07% | 32.98% | 33.79% | 34.69% | 34.90% | 35.13% | 35.58% | 38.17% | 38.73% | 96.01% | 96.09% | 96.63% | 96.61% | 100.00% | 89.03% | 90.70% | 92.39% | 92.40% | 92.20% | 92.03% | 91.46% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 227.54M | 231.40M | 263.36M | 248.95M | 404.64M | 432.38M | 417.11M | 372.57M | 305.92M | 247.53M | 218.21M | 193.54M | 170.36M | 154.27M | 124.97M | 124.97M | 119.77M | 109.06M | 115.30M | 79.45M | 76.54M | 0.00 | 274.72M | 177.72M | 148.90M | 113.70M | 81.50M | 52.70M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.20M | 0.00 | 0.00 | 0.00 | 393.14M | 350.35M | 310.78M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 227.54M | 231.40M | 263.36M | 248.95M | 404.64M | 432.38M | 417.11M | 372.57M | 305.92M | 247.53M | 218.21M | 193.54M | 170.36M | 154.27M | 147.16M | 124.97M | 119.77M | 109.06M | 508.44M | 429.80M | 387.32M | 331.48M | 274.72M | 177.72M | 148.90M | 113.70M | 81.50M | 52.70M | 29.50M | 20.70M |
| Other Expenses | 186.70M | 35.64M | 32.15M | 28.44M | 78.86M | 111.28M | 102.88M | 89.26M | 64.23M | 45.99M | 39.97M | 30.82M | 25.29M | 21.95M | 16.45M | 13.07M | 9.59M | 9.47M | 9.92M | 9.35M | 8.41M | 6.14M | 21.44M | 13.81M | 12.10M | 8.70M | 4.50M | 1.80M | 400.00K | 200.00K |
| Operating Expenses | 414.24M | 267.03M | 295.50M | 277.39M | 483.50M | 543.66M | 519.98M | 461.84M | 370.14M | 293.52M | 258.18M | 224.36M | 215.65M | 176.22M | 163.61M | 826.25M | 129.36M | 118.53M | 518.36M | 439.15M | 395.72M | 337.62M | 296.16M | 191.53M | 161.00M | 122.40M | 86.00M | 54.50M | 29.90M | 20.90M |
| Cost & Expenses | 1.99B | 1.77B | 1.69B | 1.56B | 3.11B | 3.20B | 2.98B | 2.61B | 2.22B | 1.93B | 1.70B | 1.43B | 1.25B | 1.09B | 999.34M | 826.25M | 696.74M | 620.08M | 546.03M | 463.41M | 414.31M | 353.41M | 296.16M | 218.20M | 182.10M | 136.50M | 95.80M | 60.80M | 33.40M | 23.70M |
| Interest Income | 0.00 | 3.67M | 13.65M | 17.91M | 3.69M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 42.08M | 39.70M | 68.72M | 110.48M | 119.38M | 88.77M | 74.56M | 63.09M | 23.11M | 8.89M | 5.42M | 3.25M | 3.64M | 3.19M | 2.91M | 3.59M | 749.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 36.17M | 35.64M | 32.15M | 28.44M | 25.93M | 83.83M | 102.88M | 89.26M | 64.23M | 45.99M | 39.97M | 30.82M | 25.29M | 21.95M | 16.45M | 13.07M | 10.56M | 9.47M | 9.92M | 9.35M | 8.41M | 6.14M | 21.44M | 13.81M | 12.10M | 8.70M | 4.50M | 1.80M | 400.00K | 200.00K |
| EBITDA | 29.89M | 235.64M | 249.89M | 200.37M | 258.58M | 527.69M | 587.86M | 660.95M | 622.10M | 558.99M | 492.10M | 422.23M | 382.18M | 336.30M | 307.06M | 258.22M | 224.61M | 204.11M | 156.40M | 164.68M | 145.29M | 118.21M | 79.88M | 38.68M | 57.00M | 57.60M | 37.60M | 21.80M | 10.90M | 9.30M |
| EBITDA Ratio | 1.50% | 12.04% | 13.17% | 11.65% | 14.09% | 15.46% | 16.88% | 20.86% | 22.49% | 22.99% | 22.85% | 23.14% | 23.97% | 23.89% | 23.70% | 23.88% | 24.48% | 24.94% | 22.55% | 26.58% | 26.27% | 25.22% | 22.53% | 15.77% | 24.98% | 30.74% | 27.54% | 24.50% | 23.01% | 27.74% |
| Operating Income | 7.32M | 172.69M | 202.92M | 173.52M | 416.27M | 445.85M | 480.08M | 571.69M | 557.87M | 513.00M | 452.13M | 389.52M | 355.39M | 312.91M | 288.93M | 242.03M | 220.90M | 198.47M | 147.67M | 156.22M | 136.89M | 112.08M | 58.44M | 24.87M | 44.90M | 48.90M | 33.10M | 20.00M | 10.50M | 9.10M |
| Operating Income Ratio | 0.37% | 8.76% | 10.62% | 10.01% | 11.85% | 12.22% | 13.88% | 17.96% | 20.07% | 21.03% | 20.99% | 21.44% | 22.38% | 22.33% | 22.43% | 22.66% | 24.07% | 24.25% | 21.29% | 25.21% | 24.83% | 24.08% | 16.48% | 10.23% | 19.78% | 26.38% | 25.68% | 24.75% | 23.92% | 27.74% |
| Total Other Income/Expenses | -55.68M | -91.32M | -67.69M | -90.98M | -112.97M | 120.45M | -69.65M | -57.89M | -18.14M | -4.38M | -3.72M | -1.35M | -2.14M | -1.76M | -1.23M | -611.00K | 6.11M | 2.80M | 3.70M | -402.00K | -890.00K | -338.00K | -2.23M | -3.41M | -2.30M | -400.00K | 1.70M | 2.00M | 700.00K | 0.00 |
| Income Before Tax | -48.36M | 81.37M | 135.23M | 7.15M | -1.24B | 368.84M | 410.42M | 513.80M | 539.73M | 508.62M | 448.41M | 388.17M | 353.25M | 311.15M | 287.70M | 241.42M | 227.01M | 201.28M | 146.58M | 155.82M | 136.00M | 111.74M | 56.21M | 21.46M | 42.60M | 48.50M | 34.80M | 22.00M | 11.20M | 9.10M |
| Income Before Tax Ratio | -2.42% | 4.13% | 7.08% | 0.41% | -35.35% | 10.11% | 11.87% | 16.14% | 19.41% | 20.85% | 20.82% | 21.37% | 22.24% | 22.20% | 22.33% | 22.60% | 24.74% | 24.59% | 21.13% | 25.15% | 24.67% | 24.00% | 15.85% | 8.83% | 18.77% | 26.16% | 27.00% | 27.23% | 25.51% | 27.74% |
| Income Tax Expense | 12.05M | 18.81M | 27.24M | 16.73M | -91.89M | 100.21M | 90.05M | 189.20M | 204.04M | 191.41M | 167.90M | 147.26M | 135.25M | 108.46M | 111.90M | 94.74M | 86.99M | 76.81M | 57.54M | 57.54M | 51.67M | 42.96M | 25.78M | 10.47M | 17.60M | 19.40M | 13.90M | 8.90M | 4.50M | 3.70M |
| Net Income | -60.41M | 66.34M | 130.96M | -9.58M | -1.15B | 268.63M | 320.37M | 324.91M | 336.32M | 317.28M | 280.52M | 240.91M | 218.00M | 202.69M | 175.80M | 169.20M | 142.72M | 124.47M | 89.04M | 98.28M | 84.33M | 68.78M | 30.43M | 10.99M | 25.00M | 29.10M | 20.90M | 13.10M | 6.70M | 5.40M |
| Net Income Ratio | -3.03% | 3.36% | 6.85% | -0.55% | -32.73% | 7.37% | 9.26% | 10.21% | 12.10% | 13.01% | 13.02% | 13.26% | 13.73% | 14.46% | 13.65% | 15.84% | 15.55% | 15.21% | 12.84% | 15.86% | 15.30% | 14.78% | 8.58% | 4.52% | 11.01% | 15.70% | 16.21% | 16.21% | 15.26% | 16.46% |
| EPS | -0.72 | 0.79 | 1.54 | -0.11 | -13.77 | 2.95 | 3.42 | 3.47 | 3.59 | 3.30 | 2.77 | 2.41 | 2.23 | 2.17 | 1.87 | 1.85 | 1.48 | 1.30 | 0.47 | 0.51 | 0.89 | 0.67 | 0.36 | 0.18 | 0.40 | 0.24 | 0.09 | 0.11 | 0.04 | 0.04 |
| EPS Diluted | -0.73 | 0.79 | 1.53 | -0.11 | -13.77 | 2.93 | 3.42 | 3.47 | 3.58 | 3.18 | 2.77 | 2.41 | 2.23 | 2.13 | 1.87 | 1.80 | 1.43 | 1.26 | 0.46 | 0.48 | 0.86 | 0.65 | 0.34 | 0.17 | 0.40 | 0.23 | 0.08 | 0.11 | 0.04 | 0.03 |
| Weighted Avg Shares Out | 84.02M | 83.47M | 84.83M | 83.40M | 83.50M | 91.10M | 92.43M | 92.42M | 93.74M | 96.03M | 100.91M | 99.55M | 97.87M | 93.26M | 90.92M | 92.83M | 96.92M | 95.85M | 185.94M | 190.65M | 94.97M | 102.49M | 84.64M | 63.04M | 62.05M | 60.99M | 121.13M | 116.28M | 52.20M | 52.04M |
| Weighted Avg Shares Out (Dil) | 82.20M | 84.12M | 85.83M | 83.40M | 83.50M | 91.61M | 93.72M | 93.72M | 93.96M | 99.89M | 101.21M | 100.04M | 97.87M | 95.14M | 92.94M | 94.32M | 99.81M | 98.77M | 192.16M | 198.94M | 98.31M | 106.52M | 89.91M | 64.21M | 63.44M | 63.95M | 121.13M | 116.44M | 52.20M | 52.04M |
Despite Fast-paced Momentum, Pediatrix Medical Group (MD) Is Still a Bargain Stock
MD or AVTR: Which Is the Better Value Stock Right Now?
Pediatrix Medical Group (MD) Is Attractively Priced Despite Fast-paced Momentum
Pediatrix Medical Stock Soars 30.5% Since Q3 Earnings Beat
MD vs. AVTR: Which Stock Is the Better Value Option?
Pediatrix Medical Group, Inc. (MD) Q3 2024 Earnings Call Transcript
Pediatrix Medical Group (MD) Surpasses Q3 Earnings and Revenue Estimates
Pediatrix Medical Group Reports Third Quarter Results
Pediatrix Medical Group (MD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Pediatrix Medical Group 2024 Third Quarter Conference Call/Webcast Scheduled for Friday, November 1, 2024
Source: https://incomestatements.info
Category: Stock Reports